arrow
Back
F

François Ghiringhelli

institut agro dijon

106H-index
973Paper Count
5.8WCitation Count
Published Papers 324
Publication Date
Immunohistochemistry Resolves Indeterminate MTAP Deletion Calls from Exome Sequencing: A Pan-Cancer Concordance Study
err2026-09-23
err0
errOAAI
errMarion Thibaudin; Julie Lecuelle; Anthony Bergeron; Valentin Derangere; Hugo Mananet; Léa Hampe; Susy Daumoine; Sandy Chevrier; Ana Costa; Natacha Moulharat; Maria-Elisabetta Serrentino; François Beltjens; Paul Hofman; Romain Boidot; Alis Ilie; David Rageot; Caroline Truntzer; Laurent Arnould; Francois Ghiringhelli
errShare
errSave
EGFR targeting with afatinib and cetuximab versus cetuximab alone in chemorefractory wild-type RAS metastatic colorectal cancer. A randomized phase II study with circulating tumour cell analysis.
err2026-09-18
err0
PREAI
errVictor Simmet; Astrid Lièvre; Emmanuelle Samalin; Hélène Senellart; Christelle De La Fouchardière; Christophe Borg; Antoine Adenis; David Malka; Véronique Guerin-Meyer; Ludovic Evesque; Meher Ben Abdelghani; Julien Edeline; Thierry André; Francois Ghiringhelli; Jean-Luc Raoul; Laure Monard; Sophie Gourgou; Jaafar Bennouna
errShare
errSave
Human endogenous retroviruses as immune-related prognostic biomarkers in pancreatic cancer
err2026-08-20
err0
errOAAI
errPaula Iuliana Toma; Laurentia Nicoleta Gales; Francois Ghiringhelli; Anda Trandafir; Raluca Ioana Budea; Silvia Mihaela Ilie
errShare
errSave
Usability and relevance of specialized population-based cancer registry data in externally controlled trials
err2026-08-01
err0
PREAI
errJooste, Valerie; Bouvier, Anne-Marie; Lepage, Come; Taieb, Julien; Ganame, Samhona; Ghiringhelli, Francois; Joseph, Axelle; Boussari, Olayide
errShare
errSave
Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies
err2026-06-20
err0
errOAAI
errCaroline Truntzer; Marion Thibaudin; Paula Anna Bousquet; Morgane Peroz; Valentin Derangère; Alis Ilie; David Rageot; Kjersti Flatmark; Anne Hansen Ree; Sebastian Meltzer; François Ghiringhelli
errShare
errSave
Deep learning based on CD3 histological slides for prediction of colon cancer outcome: analysis of three international stage III colon cancer cohorts
err2026-05-08
err0
errOAAI
errJulie Lécuelle; Caroline Truntzer; Debora Basile; Luigi Laghi; Luana Greco; Alis Ilie; David Rageot; Titouan Huppé; Jean-François Emile; Fréderic Bibeau; Julien Taïeb; Valentin Derangère; Come Lepage; François Ghiringhelli
errShare
errSave
MORPHEUS-Lung: biomarkers and clinical response to atezolizumab + bevacizumab + stereotactic body radiotherapy in patients with metastatic non-small cell lung cancer
err2026-05-07
err0
PREAI
errByoung Chul Cho; Sun Min Lim; Sang Hoon Lee; Dong Kwon Kim; Nuria Pardo; Hen Prizant; Yaacov R. Lawrence; Nedal Al-Sakaff; Hans-Joachim Helms; Velimir Gayevskiy; Barzin Y. Nabet; Jan Pintoffl; Francois Ghiringhelli
errShare
errSave
Hapten-Based Cancer Immunotherapy: From Immune Activation to Antitumor Activity
errCells
IF5.2
err2026-04-22
err0
errOAAI
errIseulys Richert; Lionel Chalus; Benoit Pinteur; Paul Bravetti; Corinne Tortorelli; George Alzeeb; François Ghiringhelli
errShare
errSave
Phosphatidylcholine and CHPT1 as Central Drivers of Chemoresistance in Colorectal Cancer: Lipidomic and Functional Insights
errCells
IF5.2
err2026-03-01
err0
errOAAI
errAurélie Mialhe; Jean-Paul Pais de Barros; François Hermetet; Emeric Limagne; François Ghiringhelli; Virginie Aires; Dominique Delmas
errShare
errSave
Deep learning-based assessment of PD-L1 expression in NSCLC predicts outcome for patients treated with anti-PD-1 immunotherapy
err2026-02-13
err0
errOAAI
errMorgane Peroz; Nicolas Roussot; Alis Ilie; David Rageot; Valentin Derangere; Caroline Truntzer; François Ghiringhelli
errShare
errSave
The double face of IL-1β in lung cancer
err2026-02-03
err0
errOAAI
errCédric Rébé; Anaïs Perrichet; François Ghiringhelli
errShare
errSave
Sensitive cell-free DNA assay for accurate detection of RAS and BRAF mutations in liquid biopsies of patients with metastatic colorectal cancer: Final results of the multicentric ColoBEAM study
err2026-01-01
err1
PREAI
errHarle, Alexandre; Gavoille, Celine; Bouche, Olivier; Abdelghani, Meher Ben; Plaza, Jerome; Spaeth, Dominique; Boudrant, Axelle; Ghiringhelli, Francois; Villing, Anne-Laure; Borg, Christophe; Rouyer, Marie; Husson, Marie; Gilson, Pauline; Salleron, Julia; Lambert, Aurelien; Merlin, Jean-Louis
errShare
errSave
Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm phase II trial
err2025-12-01
err0
errOAAI
errEl Kaddissi, A.; Vienot, A.; Fumet, J. -d.; Meurisse, A.; Nguyen, T.; Klajer, E.; Bouard, A.; Spehner, L.; Fein, F.; Stouvenot, M.; Dochy, E.; Rebucci-Peixoto, M.; Almotlak, H.; Henriquez, J.; Selmani, Z.; Vernerey, D.; Hervouet, E.; Folletet, A.; Kim, S.; Ghiringhelli, F.; Borg, C.
errShare
errSave
Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancer
err2025-11-21
err0
errOAAI
errAnaïs Perrichet; Julie Lecuelle; Emeric Limagne; Marie Thiefin; Hélène Bellio; Pierre Jacob; Romain Aucagne; Aziza Aznague; Pauline Russo; Flavie Gaucher; Nicolas Roussot; Xingping Yang; Thibault Vernet; Lisa Nuttin; Alis Ilie; David Rageot; Valentin Derangère; Titouan Huppe; Alfred Zippelius; Bertrand Routy; Caroline Truntzer; Fanny Chalmin; François Ghiringhelli; Cédric Rébé
errShare
errSave
Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trial
err2025-11-04
err0
errOAAI
errStefano Kim; Jihane Boustani; Soledad Iseas; Dewi Vernerey; Ludovic Evesque; Laurent Quero; Francois Ghiringhelli; Clélia Coutzac; Olivier Bouché; Benoist Chibaudel; Chloé Vernet; Angélique Vienot; David Tougeron; Thierry Nguyen; Magali Rebucci-Peixoto; Aurélia Meurisse; Sarah Chennoufi; Christophe Maritaz; Christophe Borg
errShare
errSave
CONDITIONAL SURVIVAL ANALYSIS IN IDH-MUTANT HIGH-GRADE GLIOMAS: AN USEFUL TOOL IN CLINICAL PRACTICE
err2025-11-01
err0
errOAAI
errPicca, Alberto; Belin, Lisa; Laurenge, Alice; Carpentier, Catherine; Chinot, Olivier; Moyal, Elizabeth Cohen-Jonathan; Djelad, Apolline; Bronnimann, Charlotte; Ducloie, Mathilde; Cuzzubbo, Stefania; Gourmelon, Carole; Taillandier, Luc; Younan, Nadia; Ramirez, Carole; Bauchet, Luc; Vauleon, Elodie; Langlois, Olivier; Bourg, Veronique; Dhermain, Frederic; Menei, Philippe; Seizeur, Romuald; Colin, Philippe; Ghiringhelli, Francois; Ricard, Damien; Deluche, Elise; Verlut, Clothilde; Faillot, Thierry; Khettab, Mohamed; Gaultier, Claude; Appay, Romain; Bielle, Franck; Idbaih, Ahmed; Tabouret, Emeline; Figarella-Branger, Dominique; Touat, Mehdi; Ducray, Francois; Dehais, Caroline
errShare
errSave
Interleukin-1β and cancer immune response
err2025-11-01
err0
PREAI
errCédric Rébé; François Ghiringhelli
errShare
errSave
EO2401 PEPTIDE IMMUNOTHERAPY plus NIVOLUMAB plus /- BEVACIZUMAB IN FIRST RECURRENT GLIOBLASTOMA: TREATMENT STRATEGY OPTIMIZATION IN THE PHASE 1/2 STUDY EOGBM1-18 / ROSALIE (NCT04116658)
err2025-11-01
err0
errOAAI
errReardon, David A.; Idbaih, Ahmed; Vieito, Maria; Ghiringhelli, Francois; Stradella, Agostina; Tabatabai, Ghazaleh; Burger, Michael C.; Mildenberger, Iris; Herrlinger, Ulrich; Wen, Patrick Y.; Touat, Mehdi; Wick, Antje; Gonzalez, Macarena; Hervieu, Alice; Gil-Martin, Marta; Renovanz, Mirjam; Gouttefangeas, Cecile; Maia, Ana; Chene, Laurent; Fagerberg, Jan; Rinaudo, Philippe; Wick, Wolfgang
errShare
errSave
CONDITIONAL SURVIVAL ANALYSIS IN IDH-MUTANT HIGH-GRADE GLIOMAS: AN USEFUL TOOL IN CLINICAL PRACTICE
err2025-10-01
err0
errOAAI
errPicca, A.; Belin, L.; Laurenge, A.; Carpentier, C.; Chinot, O.; Moyal, E.; Djelad, A.; Bronnimann, C.; Ducloie, M.; Cuzzubbo, S.; Gourmelon, C.; Taillandier, L.; Younan, N.; Ramirez, C.; Bauchet, L.; Vauleon, E.; Langlois, O.; Bourg, V; Dhermain, F.; Menei, P.; Seizeur, R.; Colin, P.; Ghiringhelli, F.; Ricard, D.; Deluche, E.; Verlut, C.; Faillot, T.; Khettab, M.; Gaultier, C.; Appay, R.; Bielle, F.; Idbaih, A.; Tabouret, E.; Figarella-Branger, D.; Touat, M.; Ducray, F.; Dehais, C.
errShare
errSave
A PHASE II STUDY OF AN ANTI-TERT VACCINE (UCPVAX) WITH OR WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA
err2025-10-01
err0
errOAAI
errCarpentier, A. F.; Cuzzubbo, S.; Verlut, C.; Meurisse, A.; Fumet, J.; Boullerot, L.; Bronnimann, C.; Tabouret, E.; Ursu, R.; Barsan, C.; Belin, C.; Jacquin, M.; Moltenis, M.; Kroemer, M.; Fagnoni-Legat, C.; Ghiringhelli, F.; Vernerey, D.; Laheurte, C.; Adotevi, O.
errShare
errSave